What doctors should consider before prescribing e‐liquids for e‐cigarettes

Alexander Larcombe, David Chapman and Miranda Ween
Med J Aust 2022; 217 (10): . || doi: 10.5694/mja2.51765
Published online: 21 November 2022

In reply: We thank Mendelsohn and Beaumont1 for their commitment to tobacco harm reduction and we agree that a personalised approach is likely to be most beneficial. However, nicotine prescriptions have been thrust upon Australian medical professionals with effectively no guidance, especially as to how a personalised approach should and could be implemented. Our approach takes into account current evidence to provide a foundation for prescribing e‐cigarettes until the necessary data become available.2 Our intent was to provide information for all clinicians, including general practitioners and pharmacists, especially for those with minimal experience implementing smoking cessation who may be approached to prescribe e‐cigarettes.

  • 1 Telethon Kids Institute, Perth, WA
  • 2 Curtin University, Perth, WA
  • 3 University of Technology, Sydney, Sydney, NSW
  • 4 University of Adelaide, Adelaide, SA

Competing interests:

All authors have received funding from funding bodies that are not associated with the tobacco, e‐cigarette, or smoking cessation industry.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.